Current State of Asks to Congress

Tom Kraus and Nick Gentile will be discussing the current state of ASHP’s advocacy priorities since our members went to Capitol Hill in mid-September.  They will be discussing federal provider status, protecting the 340B program, the elimination of the X waiver, and residency funding audits.   The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.